ライフサイエンスコーパス: insulin resistance syndrome

1 art disease, apparently mediated through the insulin resistance syndrome.

2 occurrence of the central components of the insulin resistance syndrome.

3 s ethnic group with a high prevalence of the insulin resistance syndrome.

4 type 1 diabetes, insulin secretion, and the insulin resistance syndrome.

5 ion of ATBF seems to be another facet of the insulin resistance syndrome.

6 ongly associated with many components of the insulin resistance syndrome.

7 d with cardiovascular disease as well as the insulin resistance syndrome.

8 g, and thus may be a candidate locus for the insulin resistance syndrome.

9 ying metabolic abnormalities observed in the insulin resistance syndrome.

10 diovascular risk factors associated with the insulin resistance syndrome.

11 t in the etiology of type 2 diabetes and the insulin resistance syndrome.

12 ll-recognized metabolic phenotype called the insulin resistance syndrome.

13 t one end of the spectrum of people with the insulin resistance syndrome.

14 ogenesis of type 2 diabetes mellitus and the Insulin Resistance Syndrome.

15 or evidence of a pattern consistent with the insulin resistance syndrome.

16 te a summary score or index representing the insulin resistance syndrome.

17 ovement in the metabolic disturbances of the insulin resistance syndrome.

18 d not appear to underlie all features of the insulin resistance syndrome.

19 ion and among subgroups with features of the insulin resistance syndrome.

20 errelated risk factors that characterize the insulin resistance syndrome.

21 tant determinants of fasting insulin and the insulin resistance syndrome.

22 the association of small, dense LDL with the insulin resistance syndrome.

23 ors may determine insulin resistance and the insulin resistance syndrome.

24 association may also be attributable to the insulin resistance syndrome.

25 ng, but developed other cardinal features of insulin resistance syndrome.

26 exacerbate the metabolic consequences of the insulin-resistance syndrome.

27 another disease considered to be part of the insulin-resistance syndrome.

28 ationship between insulin resistance and the insulin resistance syndromes.

29 rtensive rat (SHR) is a model of these human insulin resistance syndromes.

30 ption for treatment of patients with extreme insulin-resistance syndromes.

31 ay be important in the pathogenesis of human insulin-resistance syndromes.

32 uated after adjustment for components of the insulin resistance syndrome (age-adjusted OR per z score

33 of several age-related disorders, including insulin resistance syndrome, Alzheimer's disease and Hun

34 resistin in the pathophysiology of the human insulin resistance syndrome, an effect mediated by the -

35 lyceride concentration is a component of the insulin resistance syndrome and is commonly associated w

36 ive therapy are similar to those seen in the insulin resistance syndrome and may increase the risk of

37 nderlying pathophysiologic mechanisms of the insulin resistance syndrome and risk of non-insulin-depe

38 c disorders that underlie the development of insulin resistance syndrome and T2D.

39 etabolic disorders, including the metabolic (insulin resistance) syndrome and type 2 diabetes, are as

40 hat have used factor analysis to examine the insulin resistance syndrome, and explore how factor anal

41 ogical links between insulin resistance, the insulin resistance syndrome, and its sequelae is critica

42 ney disease, cardiovascular disease, and the insulin resistance syndrome, and the pathogenetic signif

43 Hypertension and insulin resistance syndrome are risk factors for cardiov

44 Severe insulin resistance syndromes are a heterogeneous group o

45 iated with obesity and other features of the insulin resistance syndrome, but given the nature of the

46 This Review aims to categorize severe insulin resistance syndromes by disease process, includi

47 o in mice have enabled us to deconstruct the insulin resistance syndromes by dissecting the contribut

48 Lipoatrophic diabetes is an insulin resistance syndrome characterized by the complet

49 R (Data from an Epidemiological Study on the Insulin Resistance Syndrome) cohort and parallel central

50 R (Data from an Epidemiological Study on the Insulin Resistance Syndrome) cohort.

51 Each element of the insulin resistance syndrome has been firmly established

52 orbidities of obesity, such as dyslipidemia, insulin resistance syndrome, hypertension, associated nu

53 ors and the subsequent development of type B insulin resistance syndrome in a woman with SLE.

54 ic insulin sensitivity and improves the full insulin resistance syndrome in vivo.

55 ur independent factors that characterize the insulin resistance syndrome in women, interpreted as 1)

56 s and atherosclerosis--often referred to as "insulin resistance syndrome." In factor analysis of data

57 The insulin resistance syndrome includes insulin resistance,

58 The insulin resistance syndrome, including abdominal obesity

59 and metabolic abnormalities associated with insulin resistance syndrome (IRS) (abnormalities in meas

60 association between microalbuminuria and the insulin resistance syndrome (IRS) among nondiabetic Nati

61 ascular disease risk factors associated with insulin resistance syndrome (IRS) do not adequately expl

62 Recently, some components of the insulin resistance syndrome (IRS) have been related to i

63 The insulin resistance syndrome (IRS) is associated with dys

64 tions among groupings of the features of the insulin resistance syndrome (IRS) on carotid intimal-med

65 An insulin resistance syndrome (IRS) score was developed ba

66 sure of risk for pathologies associated with insulin resistance syndrome (IRS) such as non-insulin-de

67 Components of the insulin resistance syndrome (IRS), including obesity, gl

68 Insulin resistance syndrome (IRS)-related phenotypes, su

69 gnoses that can be considered to make up the insulin resistance syndrome (IRS).

70 Since several insulin-resistance syndrome (IRS)-related phenotypes wer

71 The insulin resistance syndrome is increasingly recognized a

72 A major driver of this inflammation/insulin resistance syndrome is the accumulation of proin

73 The insulin resistance syndrome, manifesting as obesity and

74 Moreover, other aspects of the obesity/insulin-resistance syndrome may adversely affect efferoc

75 hesized that the genetic determinants of the insulin resistance syndrome might also predispose geneti

76 nd the metabolic indexes associated with the insulin resistance syndrome, much more research is neede

77 itions that are considered to be part of the insulin-resistance syndrome: namely, noninsulin-dependen

78 nts, identified originally from patient with insulin resistance syndrome, or inhibition of insulin an

79 positive associations with components of the insulin resistance syndrome (P<0.001).

80 The insulin resistance syndrome refers to a constellation of

81 s to examine how the major components of the insulin resistance syndrome relate to each other and to

82 t factors representing different features of insulin resistance syndrome (Syndrome X) have been ident

83 The occurrence of insulin resistance syndrome (syndrome X) is common in th

84 MA children exhibit a greater degree of the insulin resistance syndrome than NHW children, especiall

85 e conditions such as type 2 diabetes and the insulin-resistance syndrome that are associated with hyp

86 eveloped two summary measures characterizing insulin resistance syndrome to compare measures of this

87 The human insulin-resistance syndromes, type 2 diabetes, obesity,

88 he clustering of features characterizing the insulin resistance syndrome using data from 3,159 elderl

89 clustering and interdependence of groups of insulin resistance syndrome variables.

90 duction in breast cancer risk for women with insulin resistance syndrome who consume high-fat diets a